149 related articles for article (PubMed ID: 35612488)
1. Structure-Aided Design, Synthesis, and Biological Evaluation of Potent and Selective Non-Nucleoside Inhibitors Targeting Protein Arginine Methyltransferase 5.
Rong D; Zhou K; Fang W; Yang H; Zhang Y; Shi Q; Huang Y; Li J; Dong H; Li L; Ding J; Huang X; Wang Y
J Med Chem; 2022 Jun; 65(11):7854-7875. PubMed ID: 35612488
[TBL] [Abstract][Full Text] [Related]
2. Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors.
Chen Y; Wang Z; Zhang J; Shi Q; Yang H; Deng Y; Wang X; Liu T; Geng M; Xiong B; Huang X
Eur J Med Chem; 2024 Mar; 267():116171. PubMed ID: 38301329
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study of a series of nucleoside derivatives bearing sulfonamide scaffold as potent and selective PRMT5 inhibitors.
Chen Y; Shi Q; Yang H; Li J; Zhou K; Zhang J; Wang Z; Shi H; Xiong B; Liu J; Huang X; Liu T
Bioorg Chem; 2023 Jan; 130():106228. PubMed ID: 36356371
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors.
Lin H; Luengo JI
Bioorg Med Chem Lett; 2019 Jun; 29(11):1264-1269. PubMed ID: 30956011
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.
Zhu K; Song JL; Tao HR; Cheng ZQ; Jiang CS; Zhang H
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3693-3699. PubMed ID: 30366617
[TBL] [Abstract][Full Text] [Related]
6. Arginine Methyltransferase 5 (PRMT5) Inhibitors with 3-(1H-benzo[d]imidazol- 2-yl)anilines Core Identified by Virtual Screening and Biological Evaluation.
Zhang Y; Zhu K; Zhang J; Zhang JH; Song Z; Zhang X; Liu SK; Jiang CS
Curr Pharm Des; 2023; 29(6):474-479. PubMed ID: 36790004
[TBL] [Abstract][Full Text] [Related]
7. Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening.
Ye Y; Zhang B; Mao R; Zhang C; Wang Y; Xing J; Liu YC; Luo X; Ding H; Yang Y; Zhou B; Jiang H; Chen K; Luo C; Zheng M
Org Biomol Chem; 2017 May; 15(17):3648-3661. PubMed ID: 28397890
[TBL] [Abstract][Full Text] [Related]
8. Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity.
Zhu K; Shao J; Tao H; Yan X; Luo C; Zhang H; Duan W
J Comput Aided Mol Des; 2019 Aug; 33(8):775-785. PubMed ID: 31312965
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations.
Zhu K; Jiang C; Tao H; Liu J; Zhang H; Luo C
Bioorg Med Chem Lett; 2018 May; 28(9):1476-1483. PubMed ID: 29628326
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation.
Shao J; Zhu K; Du D; Zhang Y; Tao H; Chen Z; Jiang H; Chen K; Luo C; Duan W
Eur J Med Chem; 2019 Feb; 164():317-333. PubMed ID: 30605830
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel PRMT5 inhibitors bearing a methylpiperazinyl moiety.
Bai X; Zhai Z; Zhao X; Li R; Liang L; Jin Y; Yin Y
Future Med Chem; 2022 Jul; 14(14):1071-1086. PubMed ID: 35748226
[No Abstract] [Full Text] [Related]
12. Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders.
Shen Y; Gao G; Yu X; Kim H; Wang L; Xie L; Schwarz M; Chen X; Guccione E; Liu J; Bedford MT; Jin J
J Med Chem; 2020 Sep; 63(17):9977-9989. PubMed ID: 32787082
[TBL] [Abstract][Full Text] [Related]
13. The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.
Quiroz RV; Reutershan MH; Schneider SE; Sloman D; Lacey BM; Swalm BM; Yeung CS; Gibeau C; Spellman DS; Rankic DA; Chen D; Witter D; Linn D; Munsell E; Feng G; Xu H; Hughes JME; Lim J; Saurí J; Geddes K; Wan M; Mansueto MS; Follmer NE; Fier PS; Siliphaivanh P; Daublain P; Palte RL; Hayes RP; Lee S; Kawamura S; Silverman S; Sanyal S; Henderson TJ; Ye Y; Gao Y; Nicholson B; Machacek MR
J Med Chem; 2021 Apr; 64(7):3911-3939. PubMed ID: 33755451
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Activity of Triazole-Adenosine Analogs as Protein Arginine Methyltransferase 5 Inhibitors.
Brown T; Cao M; Zheng YG
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744905
[TBL] [Abstract][Full Text] [Related]
15. Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.
Ji S; Ma S; Wang WJ; Huang SZ; Wang TQ; Xiang R; Hu YG; Chen Q; Li LL; Yang SY
Chem Biol Drug Des; 2017 Apr; 89(4):585-598. PubMed ID: 27714957
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy.
Tang Y; Huang S; Chen X; Huang J; Lin Q; Huang L; Wang S; Zhu Q; Xu Y; Zou Y
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235174
[TBL] [Abstract][Full Text] [Related]
17. Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery.
Wang Y; Hu W; Yuan Y
J Med Chem; 2018 Nov; 61(21):9429-9441. PubMed ID: 29870258
[TBL] [Abstract][Full Text] [Related]
18. Discovery of tetrahydroisoquinolineindole derivatives as first dual PRMT5 inhibitors/hnRNP E1 upregulators: Design, synthesis and biological evaluation.
Chu WH; Yang N; Zhang JH; Li Y; Song JL; Deng ZP; Meng N; Zhang J; Zhu KK; Jiang CS
Eur J Med Chem; 2023 Oct; 258():115625. PubMed ID: 37429083
[TBL] [Abstract][Full Text] [Related]
19. Identification of PRMT5 inhibitors with novel scaffold structures through virtual screening and biological evaluations.
Zhang Q; Zhang L; Jin J; Fan Y; Wang X; Hu H; Ye X; Wang L; Cao C; Ye F
J Mol Model; 2022 Jun; 28(7):184. PubMed ID: 35680707
[TBL] [Abstract][Full Text] [Related]
20. Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer.
Guo C; Wu L; Zheng X; Zhao L; Hou X; Wang Z; Han C
Curr Top Med Chem; 2023; 23(21):2048-2074. PubMed ID: 37438905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
